GPT and Cirrhosis: As shown from Table 1 and Fig. 3A, approximately 55% (110/200) of patients with CHB-related cirrhosis and normal or minimally increased ALT levels had significant liver damage, and the liver necroinflammation was not affected by antiviral treatment (P = 0.208).